Sammy Ferri-Borgogno

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center

Affiliated withThe University of Texas MD Anderson Cancer Center

Research Area

Biography

Sammy Ferri-Borgogno has not added Biography.
If you are Sammy Ferri-Borgogno and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 5	Year
Publication title Cited by 1	2025
Publication title	2025
Publication title	2025
Publication title	2025
Publication title	2025

Other Publications

Article	Year
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget\| PubMed ID: 26734996	2016
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nature communications\| PubMed ID: 30651550	2019
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. JCI insight\| PubMed ID: 31557131
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers\| PubMed ID: 32867127	2020
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436. Cancers\| PubMed ID: 33557446	2021
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers\| PubMed ID: 33917869	2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Molecular metabolism\| PubMed ID: 34971802	2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO precision oncology\| PubMed ID: 35050739	2020
Spontaneous tumor regression following COVID-19 vaccination. Journal for immunotherapy of cancer\| PubMed ID: 35241495	2022
Ryanodine receptor 1-mediated Ca signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. Journal of experimental & clinical cancer research : CR\| PubMed ID: 35953818	2022
Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors. Cancer research\| PubMed ID: 36787106	2023
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors. Molecular cancer research : MCR\| PubMed ID: 37068116	2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 37256648	2023
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses. Cancers\| PubMed ID: 38473208	2024
Spatial transcriptome reveals histology-correlated immune signature learnt by deep learning attention mechanism on H&E-stained images for ovarian cancer prognosis. Journal of translational medicine\| PubMed ID: 39856778	2025
Learning directed acyclic graphs for ligands and receptors based on spatially resolved transcriptomic data of ovarian cancer. Briefings in bioinformatics\| PubMed ID: 40062614	2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics. Gynecologic oncology\| PubMed ID: 40279981	2025
Multimodal spatial proteomic profiling in acute myeloid leukemia. NPJ precision oncology\| PubMed ID: 40394148	2025
Multiplexed imaging mass cytometry reveals tumor-immune microenvironment-dependent hormone receptor expression in adult type ovarian granulosa cell tumors. Cancer research communications\| PubMed ID: 41042551	2025